Kavoosi G, Ardestani S K, Kariminia A
Institute of Biotechnology, University of Shiraz, Shiraz, Iran.
Parasitology. 2009 Sep;136(10):1193-9. doi: 10.1017/S0031182009990473. Epub 2009 Jul 27.
In the present study, we show for the first time that lipophosphoglycan (LPG) stimulated cytokine production by human peripheral blood mononuclear cells is also mediated via Toll-like receptor (TLR2). In addition, in order to verify if TLR2 is involved in recognition of the purified PGs, neutralizing mAbs against TLR2 and TLR4 were used to treat the cells before being stimulated with PGs. We found strong Th1-promoting cytokines induced by sLPG but not by mLPG which was blocked by presence of anti-TLR2 mAb. This finding reveals a mechanism by which the first encounter and recognition of L. major promastigotes by mLPG after interaction with TLR2 provides a cytokine milieu for consequent Th2 differentiation. Moreover, having shown the strong induction of Th1-promoting cytokines and low production of IL-10 in response to sLPG might have vaccine implication since it is recognized by TLR2 providing signals to professional antigen presenting cells that reside in the skin to promote effective T cell responses against Leishmania infection. In addition, it was shown that purified mLPG and sLPG activate reactive oxygen species (ROS) production which is also blocked by anti-TLR2 but not by anti-TLR4. However, no inhibition was seen in PPG-induced cytokine and ROS production in the presence of anti-TLR2 and anti-TLR4, implying involvement of other receptors.
在本研究中,我们首次表明,人外周血单核细胞受脂磷壁酸聚糖(LPG)刺激产生细胞因子也是通过Toll样受体(TLR2)介导的。此外,为了验证TLR2是否参与纯化的糖蛋白(PGs)的识别,在用PGs刺激细胞之前,使用针对TLR2和TLR4的中和单克隆抗体(mAbs)处理细胞。我们发现,可溶性LPG(sLPG)可诱导强烈的Th1促进细胞因子产生,而甘露糖结合LPG(mLPG)则不能,抗TLR2 mAb的存在可阻断mLPG诱导的细胞因子产生。这一发现揭示了一种机制,即mLPG与TLR2相互作用后首次接触并识别硕大利什曼原虫前鞭毛体,为随后的Th2分化提供了细胞因子环境。此外,鉴于sLPG可被TLR2识别,从而向驻留在皮肤中的专业抗原呈递细胞提供信号,以促进针对利什曼原虫感染的有效T细胞反应,因此,sLPG可强烈诱导Th1促进细胞因子产生且IL-10产生量低这一现象可能具有疫苗意义。此外,研究表明,纯化的mLPG和sLPG可激活活性氧(ROS)的产生,抗TLR2可阻断这一过程,而抗TLR4则不能。然而,在抗TLR2和抗TLR4存在的情况下,PPG诱导的细胞因子和ROS产生未受抑制,这意味着其他受体也参与其中。